Mazzeo S, Caramella D, Lencioni R, Molea N, De Liperi A, Marcocci C, Miccoli P, Iacconi P, Bossio G B, Viacava P, Lazzeri E, Bartolozzi C
Department of Radiology, University of Pisa, Italy.
AJR Am J Roentgenol. 1996 Jun;166(6):1465-70. doi: 10.2214/ajr.166.6.8633466.
This study prospectively evaluated the sensitivity of high-resolution sonography compared with double-tracer 201Tl-99mTc scintigraphy (Tl-Tc) subtractive scintigraphy and double-phase 99mTc-sestamibi (Tc-MIBI) scintigraphy prior to surgery in the assessment of patients with primary hyperparathyroidism in a geographic region where areas of endemic thyroid goiter are present.
Sonography and scintigraphy were used as first-step imaging procedures in 73 patients with primary hyperparathyroidism. In 30 (41%) of 73 cases, we found an association with a thyroid abnormality. We compared sonography with double-tracer Tl-Tc scintigraphy in 41 cases, with Tc-MIBI scintigraphy in 22 other cases, and with both scintigraphic studies in 10 other cases.
Surgery demonstrated 68 solitary parathyroid lesions (66 adenomas, one hyperplasia, and one carcinoma), two adenomas in two patients, and multiple hyperplastic glands in two patients for a total of seven lesions. In one case no abnormal parathyroid gland was found. Overall sensitivity of sonography, Tl-Tc, and Tc-MIBI scintigraphy was 85%, 62%, and 82%, respectively. In patients with concomitant thyroid disease, the sensitivity of sonography, dual-tracer Tl-Tc, and Tc-MIBI was 77%, 67%, and 80%, respectively.
Our study proves that sonography and scintigraphy are equally able to detect parathyroid lesions before surgery in patients with concomitant thyroid diseases. In patients without thyroid abnormalities, detection rates of sonography and Tc-MIBI do not show any statistical difference, and the detection rate of Tl-Tc is significantly inferior to that of sonography. Sonography alone should be used as the first step for localization of abnormal parathyroid glands prior to surgery, and Tc-MIBI scintigraphy should be used as the second step when sonography is negative.
本研究前瞻性评估了在存在地方性甲状腺肿区域的原发性甲状旁腺功能亢进患者术前,高分辨率超声与双示踪剂201Tl - 99mTc闪烁扫描(Tl - Tc)减影闪烁扫描及双期99mTc - 甲氧基异丁基异腈(Tc - MIBI)闪烁扫描相比的敏感性。
超声检查和闪烁扫描作为73例原发性甲状旁腺功能亢进患者的第一步成像检查方法。在73例中的30例(41%)中,我们发现与甲状腺异常有关联。我们将41例患者的超声检查与双示踪剂Tl - Tc闪烁扫描进行比较,22例患者的超声检查与Tc - MIBI闪烁扫描进行比较,另外10例患者的超声检查与两种闪烁扫描研究进行比较。
手术发现68个孤立性甲状旁腺病变(66个腺瘤、1个增生和1个癌),2例患者各有2个腺瘤,2例患者有多发性增生性腺,共7个病变。1例未发现异常甲状旁腺。超声、Tl - Tc和Tc - MIBI闪烁扫描的总体敏感性分别为85%、62%和82%。在伴有甲状腺疾病的患者中,超声、双示踪剂Tl - Tc和Tc - MIBI的敏感性分别为77%、67%和80%。
我们的研究证明,在伴有甲状腺疾病的患者中,超声和闪烁扫描在术前检测甲状旁腺病变的能力相当。在无甲状腺异常的患者中,超声和Tc - MIBI的检测率无统计学差异,而Tl - Tc的检测率明显低于超声。术前超声检查应单独作为异常甲状旁腺定位的第一步,当超声检查结果为阴性时,Tc - MIBI闪烁扫描应作为第二步检查。